FDA approves Nevro's Senza pain device ahead of schedule

The FDA approves Nevro's Senza implantable pain device ahead of schedule and allows it claim superiority to other spinal cord stimulation devices; 1st-quarter sales and earnings top expectations.

Food & Drug Administration (FDA), Nevro Corp.

News Well, MassDevice.com Earnings Roundup, 2015, Neuromodulation/Neurostimulation, Pre-Market Approval (PMA), Q1, Regulatory/Compliance

read more

from MassDevice - FDA and Medical device business news and jobs for the medical device industry http://ift.tt/1ARmgfy